Ageing and Fertility: Biology Comes Second
By Kirsty Oswald,
BioNews
| 08. 10. 2015
The association between a woman's age and her fertility never seems far from the news but recently there has been a veritable bombardment of opinion over what age a woman should have a child.
We are repeatedly reminded that a woman's fertility drops off a cliff after age 40. Or was it 35? Or 38? I don't remember. And it depends which week you ask.
How does this keep making headlines time and time again, when each finding seems so unauthoritative and inconsistent it might as well have been picked from a hat?
It would appear we cannot resist a biologically authorised opportunity to tell a woman what to do with her body. But all this talk of the age a woman's fertility 'drops off a cliff' is just a distractor from the truth – this phenomenon of women finding themselves 'up against' the biological clock is a cultural one, not a biological one.
Read more...
Image via Wikimedia Commons.
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
